Bruker Corp (BRKR)
77.95
+2.28
(+3.01%)
USD |
NASDAQ |
May 15, 15:05
Bruker Cash from Operations (Quarterly): 21.80M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 21.80M |
December 31, 2023 | 205.50M |
September 30, 2023 | 44.10M |
June 30, 2023 | 13.00M |
March 31, 2023 | 87.50M |
December 31, 2022 | 171.50M |
September 30, 2022 | 69.50M |
June 30, 2022 | -44.40M |
March 31, 2022 | 77.80M |
December 31, 2021 | 138.60M |
September 30, 2021 | 23.90M |
June 30, 2021 | 21.90M |
March 31, 2021 | 98.00M |
December 31, 2020 | 203.00M |
September 30, 2020 | 82.40M |
June 30, 2020 | 11.80M |
March 31, 2020 | 35.00M |
December 31, 2019 | 136.20M |
September 30, 2019 | 52.40M |
June 30, 2019 | 10.60M |
March 31, 2019 | 14.20M |
December 31, 2018 | 132.30M |
September 30, 2018 | 27.50M |
June 30, 2018 | 36.10M |
March 31, 2018 | 43.80M |
Date | Value |
---|---|
December 31, 2017 | 103.70M |
September 30, 2017 | 35.30M |
June 30, 2017 | -17.20M |
March 31, 2017 | 32.60M |
December 31, 2016 | 90.80M |
September 30, 2016 | 35.90M |
June 30, 2016 | 18.10M |
March 31, 2016 | -14.00M |
December 31, 2015 | 149.60M |
September 30, 2015 | 54.10M |
June 30, 2015 | -1.50M |
March 31, 2015 | 27.00M |
December 31, 2014 | 69.30M |
September 30, 2014 | 13.50M |
June 30, 2014 | 13.00M |
March 31, 2014 | 18.50M |
December 31, 2013 | 131.40M |
September 30, 2013 | 38.50M |
June 30, 2013 | -6.70M |
March 31, 2013 | -18.20M |
December 31, 2012 | 90.90M |
September 30, 2012 | 0.30M |
June 30, 2012 | 37.10M |
March 31, 2012 | 4.80M |
December 31, 2011 | 92.10M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-44.40M
Minimum
Jun 2022
205.50M
Maximum
Dec 2023
73.00M
Average
60.95M
Median
Cash from Operations (Quarterly) Benchmarks
NanoString Technologies Inc | -19.70M |
Azenta Inc | 8.356M |
Harvard Bioscience Inc | 1.403M |
Bionano Genomics Inc | -28.13M |
Akoya Biosciences Inc | -5.584M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -304.20M |
Cash from Financing (Quarterly) | 151.70M |
Free Cash Flow | 181.10M |
Free Cash Flow Per Share (Quarterly) | 0.0027 |
Free Cash Flow to Equity (Quarterly) | -96.60M |
Free Cash Flow to Firm (Quarterly) | 2.136M |
Free Cash Flow Yield | 1.58% |